Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W L Hewitt

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Clinical Pharmacology and Therapeutics|November 1, 1975
Panel 3: phase III investigationsD L Azarnoff, W B Abrams, J Cuttner, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1978
In vitro studies of piperacilin, a new semisynthetic penicillinD J Winston, D Wang, L S Young, et al.
The Journal of Antimicrobial Chemotherapy|February 1, 1982
In-vitro activity of Sch 29482--a new penem antibioticR L Muench, A L Mayhew, J A Hindler, et al.
Archives of Internal Medicine|September 1, 1982
Piperacillin plus amikacin therapy v carbenicillin plus amikacin therapy in febrile, granulocytopenic patientsD J Winston, W G Ho, L S Young, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1976
Ototoxicity of amikacinR E Black, W K Lau, R J Weinstein, et al.
The Journal of Infectious Diseases|June 1, 1971
Pyelonephritis. XII. Comparison of penicillin, ampicillin, and streptomycin in enterococcal infection in ratsF L Sapico, G M Kalmanson, J Z Montgomerie, et al.
California Medicine|December 1, 1971
Maternal and neonatal Australia antigenT F Keys, C J Hobel, S Ritman, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1980
Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilliT O Kurtz, D J Winston, J A Hindler, et al.
The American Journal of Medicine|June 1, 1977
Comparative efficacy and toxicity of amikacin/carbenicillin versus gentamicin/carbenicillin in leukopenic patients: a randomized prospective trailW K Lau, L S Young, R E Black, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Clinical Pharmacology and Therapeutics|November 1, 1975
Panel 3: phase III investigationsD L Azarnoff, W B Abrams, J Cuttner, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1978
In vitro studies of piperacilin, a new semisynthetic penicillinD J Winston, D Wang, L S Young, et al.
The Journal of Antimicrobial Chemotherapy|February 1, 1982
In-vitro activity of Sch 29482--a new penem antibioticR L Muench, A L Mayhew, J A Hindler, et al.
Archives of Internal Medicine|September 1, 1982
Piperacillin plus amikacin therapy v carbenicillin plus amikacin therapy in febrile, granulocytopenic patientsD J Winston, W G Ho, L S Young, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1976
Ototoxicity of amikacinR E Black, W K Lau, R J Weinstein, et al.
The Journal of Infectious Diseases|June 1, 1971
Pyelonephritis. XII. Comparison of penicillin, ampicillin, and streptomycin in enterococcal infection in ratsF L Sapico, G M Kalmanson, J Z Montgomerie, et al.
California Medicine|December 1, 1971
Maternal and neonatal Australia antigenT F Keys, C J Hobel, S Ritman, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1980
Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilliT O Kurtz, D J Winston, J A Hindler, et al.
The American Journal of Medicine|June 1, 1977
Comparative efficacy and toxicity of amikacin/carbenicillin versus gentamicin/carbenicillin in leukopenic patients: a randomized prospective trailW K Lau, L S Young, R E Black, et al.
Pageof 5